These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17315909)

  • 1. Large-scale proteomics analysis of human ovarian cancer for biomarkers.
    Bengtsson S; Krogh M; Szigyarto CA; Uhlen M; Schedvins K; Silfverswärd C; Linder S; Auer G; Alaiya A; James P
    J Proteome Res; 2007 Apr; 6(4):1440-50. PubMed ID: 17315909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of proteomics in ovarian cancer: which sample should be used?
    Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
    Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classifications of ovarian cancer tissues by proteomic patterns.
    Zhu Y; Wu R; Sangha N; Yoo C; Cho KR; Shedden KA; Katabuchi H; Lubman DM
    Proteomics; 2006 Nov; 6(21):5846-56. PubMed ID: 17068758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor vascular proteins as biomarkers in ovarian cancer.
    Buckanovich RJ; Sasaroli D; O'Brien-Jenkins A; Botbyl J; Hammond R; Katsaros D; Sandaltzopoulos R; Liotta LA; Gimotty PA; Coukos G
    J Clin Oncol; 2007 Mar; 25(7):852-61. PubMed ID: 17327606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
    Gortzak-Uzan L; Ignatchenko A; Evangelou AI; Agochiya M; Brown KA; St Onge P; Kireeva I; Schmitt-Ulms G; Brown TJ; Murphy J; Rosen B; Shaw P; Jurisica I; Kislinger T
    J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
    Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A; Ye B
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression patterns associated with advanced stage ovarian cancer.
    Cortesi L; Rossi E; Della Casa L; Barchetti A; Nicoli A; Piana S; Abrate M; La Sala GB; Federico M; Iannone A
    Electrophoresis; 2011 Aug; 32(15):1992-2003. PubMed ID: 21728179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling of peritoneal rinse fluid sediment separates patients with ovarian cancer from women admitted for cesarean section. A pilot study.
    Honoré B; Vorum H; Knudsen A
    Scand J Clin Lab Invest; 2010 Nov; 70(7):470-7. PubMed ID: 20704521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.
    Cadron I; Van Gorp T; Amant F; Vergote I; Moerman P; Waelkens E; Daemen A; Van De Plas R; De Moor B; Zeillinger R
    Anticancer Res; 2009 Apr; 29(4):1039-45. PubMed ID: 19414343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
    Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
    Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ovarian cancer-derived secretory/releasing proteome: A repertoire of tumor markers.
    Zhang Y; Xu B; Liu Y; Yao H; Lu N; Li B; Gao J; Guo S; Han N; Qi J; Zhang K; Cheng S; Wang H; Zhang X; Xiao T; Wu L; Gao Y
    Proteomics; 2012 Jun; 12(11):1883-91. PubMed ID: 22623176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.
    Gadducci A; Cosio S; Tana R; Genazzani AR
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):12-27. PubMed ID: 18595727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer.
    Bertenshaw GP; Yip P; Seshaiah P; Zhao J; Chen TH; Wiggins WS; Mapes JP; Mansfield BC
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2872-81. PubMed ID: 18843033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.